| mRNA |
Ki8751 |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
7e-10 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-09 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-08 |
| mRNA |
KW-2449 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-08 |
| mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-08 |
| mRNA |
tacrolimus |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-08 |
| mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-08 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-08 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-07 |
| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-07 |